baber/WOPTO huggingface dataset:
Patent FI-905728-A0 (FI)
Inventor: GERKEMA HEIN
IPC: B65B27/10
Filed: 1990-11-20
Abstract: A bundling apparatus for clamping elongate articles (20-23) into a bundle, the apparatus having a zone into which the articles are brought for bundling, and an elongate flexible element (11) suspended so as to form a loop at least partly surrounding said zone. A pair of swingable tensioning arms (3,4) each has a contact member (9,10) for engaging the clamping element (11) from outside the loop and is swingable in a path about an axis (5) in a manner such that the contact member (9,10) moves above said zone while pushing said clamping element, the contact members (3,4) thus cooperate to effect tightening of the loop. The paths of swinging of said arms are arranged so that said arms are able to cross each other during their swinging movement.
Patent FI-914375-A0 (FI)
Inventor: PIRCHL GERHARD
IPC: F24D3/14
Filed: 1991-09-18
Abstract: The tile described has a heat-conducting layer (10) located between an insulating layer (2) and a load-distribution layer (12). The insulating layer (2) has a recess (6) designed to hold a tube (8) through which a heat-carrying fluid passes. In order to avoid hotspots in the load-distribution layer (12) above the tube (8), insulation (20, 20a) is fitted between the load-distribution layer (12) and the tube (8).
Patent FI-941282-A0 (FI)
Inventor: MOGENSEN PEDER
IPC: B07B1/28
Filed: 1994-03-18
Abstract: A method for separating a collection of particles according to size, shape and/or density, whereby the collection of particles being fed through a vibrating space with classifying elements (1,7-11) in the form of screen cloths, wires or bars. The invention is characterized by that the classifying elements have a more vigorous movement (3) mostly perpendicular to the classifying elements near the inlet end of the space and a more gentle movement (4) which is more horizontal at the outlet end of the space. <IMAGE>   <IMAGE>
Patent FI-942941-A0 (FI)
Inventor: EIBL JOHANN
IPC: A61P9/00
Filed: 1994-06-17
Abstract: The use of human Protein C for the prevention and treatment of deposition or aggregation of thrombocytes, microparticles of thrombocytes, and leucocytes is described. In addition, an improved method for the extra-corpereal treatment of body fluids is disclosed.   <IMAGE>
Patent FI-944496-A0 (FI)
Inventor: BEISSWANGER RUDOLF
IPC: D21H25/12
Filed: 1994-09-28
Abstract: The coating is applied at stations. Part of the total coating is applied at each station, and the sum of the coating stations equals the amt. of coating to be applied. The paper web is dried between each coating station. Pref. coating station which gives an indirect cladding action comprises two parallel rollers with a gap between them for the paper web to pass through. Applicator jet(s) is directed at the mantle surface of one roller for the coating medium to be transferred to the web at the roller gap. Each coating station delivers only part of the total coating, and a dryer is after each station. The total vol. of coating material is pref. initially applied to one side of the web, required for that side, and the web is dried. The amt. of coating required for the other side is then applied, and the web is dried again. With station(s) part of the coating is applied and the web is dried, and a further station where the remainder of the coating is applied and the web is dried again. The amt. of coating applied to each side of the web is more than 3 g/m2, e.g. 4-8 g/m2. After each coating, the web is dried to less than 70% of the dry rating. Each station is pref. a double coating station, with a jet directed at each roller mantle. Or each station is a single applicator station, with a jet directed at only one roller mantle. In the assembly, station(s) is a double unit and station(s) is a single applicator machine.
Patent FI-950888-A0 (FI)
Inventor: FISCHER BERNHARD
IPC: C07K1/18
Filed: 1995-02-27
Abstract: A process for the sepn. of vitamin=K dependent proteins from non-vitamin=K dependent proteins by the addn. of Ca<2+> to a protein-contg. soln., and contacting the soln. with an anion exchanger so that all proteins except the vitamin=K-dependent ones are adsorbed is claimed.
Patent FI-954530-A0 (FI)
Inventor: BERGLOEF FREDRIK
IPC: G09F7/04
Filed: 1995-09-25
Abstract: PCT No. PCT/SE94/00273 Sec. 371 Date Nov. 6, 1995 Sec. 102(e) Date Nov. 6, 1995 PCT Filed Mar. 25, 1994 PCT Pub. No. WO94/23409 PCT Pub. Date Oct. 13, 1994A magnetic fastening device comprises a magnetic attraction member (11, 12) including a permanent magnet (16, 17) and an elongate tubular sheath (13) which is made of nonmagnetic material and tightly encloses the magnetic attraction member (12, 13). Two magnetic attraction members may be interconnected by a flexible hinge member which is integral with the sheaths of the members and formed from a length (13) of shrink tubing.
Patent FI-954541-A0 (FI)
Inventor: PIERCE GLENN F
IPC: A61K38/00
Filed: 1995-09-25
Abstract: Based on extensive in vivo studies in animals, it has now been discovered that KGF stimulates proliferation, growth and differentiation in various cells of epithelial tissue, besides keratinocytes. This better understanding of the biological effects of KGF in vivo enables the use of this polypeptide as a therapeutic agent, suitably formulated in a pharmaceutical composition, for the specific treatment of disease states and medical conditions afflicting tissues and organs such as the dermal adnexae, the liver, the lung, and the gastrointestinal tract.
Patent FI-963911-A0 (FI)
Inventor: VIMPARI MARKKU
IPC: H04M3/30
Filed: 1996-09-30
Abstract: The invention concerns a system implementing a wireless subscriber connection and comprising base stations and wireless terminals. The terminal contains functions which may be used for testing the terminal, the subscriber terminal equipment and the connection between them in response to a message which is received via a radio path and which starts the test functions, and which transmit the test results to a radio link. The terminal contains a subscriber line interface circuit (SLIC) with which the subscriber terminal equipment may be connected to the terminal. A connecting line may be used for connecting. Means for generating an alternating voltage may be connected in parallel with the input of the subscriber line interface circuit (SLIC) and the connecting line. A table is stored in the terminal's memory containing function specifications, and in response to the message starting the test functions the terminal searches the table for the function specification and performs the test tasks according to the specification. The tasks also comprise loop measurements.
Patent FI-972384-A0 (FI)
Inventor: BOEHM HANS JOACHIM
IPC: A61K38/55
Filed: 1997-06-05
Abstract: PCT No. PCT/EP95/04646 Sec. 371 Date Jun. 5, 1997 Sec. 102(e) Date Jun. 5, 1997 PCT Filed Nov. 25, 1995 PCT Pub. No. WO96/17860 PCT Pub. Date Jun. 13, 1996Compounds of the formula I    <IMAGE>  I  in which R1, A and B have the meanings stated in the description, and the preparation thereof are described. The novel compounds are suitable for controlling diseases.
Patent IL-60418-A0 (IL)
Title: Benzoyl derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D295/155
Filed: 1980-06-27
Abstract: Compounds of the formula   <IMAGE>   wherein each X, which may be identical or different from the other X, is oxygen or imino; R1 is hydrogen, fluorine, chlorine or bromine; R2 and R3, which may be identical or different from each other, are each hydrogen; unsubstituted or mono-substituted alkyl of 1 to 6 carbon atoms, where the substituent is phenyl or dialkylamino with 1 to 3 carbon atoms in each alkyl moiety; pyridyl; or cycloalkyl of 5 to 7 carbon atoms; R2 and R3, together with each other and the nitrogen atoms to which they are attached, are pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-aryl-piperazino or N-(alkyl of 1 to 3 carbon atoms)-piperazino; A is cycloalkylene of 5 to 7 carbon atoms; unsubstituted or substituted alkylene of 2 to 10 carbon atoms, where the substituents are one to two alkyls of 1 to 3 carbon atoms each, one to two carbalkoxys of 2 to 4 carbon atoms each, one to two phenyls, one to four hydroxyls, one halomethyl, one hydroxymethyl, one alkanoyloxy of 1 to 18 carbon atoms, one alkanoyloxymethyl of 1 to 18 carbon atoms in the alkanoyl moiety or one   <IMAGE>  where R1, R2 and R3 have the meanings previously defined; or alkylene of 2 to 10 carbon atoms interrupted by oxygen, sulfur, sulfoxide, sulfonyl, phenyl, cyclohexyl, pyridyl, piperazino or unsubstituted or substituted imino, where the substituent on the imino group is alkyl of 1 to 6 carbon atoms, phenyl or phenylalkyl of 1 to 3 carbon atoms in the alkyl moiety; B is the acyl residue of an antiphlogistic carboxylic acid; and their non-toxic, pharmacologically acceptable acid addition salts. The compounds as well as their salts are useful as anti-inflammatories.
Patent IL-61343-A0 (IL)
Title: Process for the preparation of 1,2,4-triazole
IPC: C07D249/08
Filed: 1980-10-24
Abstract: 1,2,4-triazole is obtained by cyclization of N,N'-diformylhydrazine with ammonia in the presence of formamide. The amount of ammonia required is either formed in situ from thermally decomposable ammonium salts, or supplied by feeding in gaseous ammonia. Simultaneously, the water of reaction is constantly distilled off from the system.
Patent IL-65964-A0 (IL)
Title: Production of 5,5-disubstituted 3-oxopent-4-enoic acids and halides,esters,thioesters and amides thereof,and antifungal and antibacterial compositions containing them
IPC: C07C303/22
Filed: 1982-06-03
Abstract: A process is described for the production of a compound having the formula:  R<2>R<2>C=CHCOCH2COZ I wherein R<2> is fluorine, chlorine, or bromine; R<3> is hydrogen, fluorine, chlorine or bromine, or a group of formula -CR<4>R<5>R<6> wherein R<4>, R<5> and R<6> are fluorine, chlorine or bromine; and Z is -AY or X<1> wherein A is -O-, -S- or -NR<7> wherein R<7> is hydrogen, C1-10 - straight - or branch chain alkyl or C3-4 straight or branch chain alkenyl, Y is hydrogen, C 1-18-straight or branch chain alkyl optionally interrrupted by one to five oxygen atoms and optionally substituted by one to five chlorine or bromine atoms, or by a group having the formula -OR<8> or the formula -CO2R<9> wherein R<8> is hydrogen, C3-12-cycloalkyl, straight- or branch chain C3-18-alkenyl, C6-10-aryl or C7-13-aralkyl and R<9> is hydrogen, C1-18-straight- or branch chain alkyl or straight- or branch chain C3-18-alkenyl, or Y is C3-18 straight or branch chain alkenyl, C3-18 straight- or branch chain alkynyl, C3-12-cycloalkyl, C7-13-aralkyl, or C6-10- aryl which is optionally substituted by one to three C1-9 straigth- or branch chain alkyl, halogen, nitro, CF3, or SO3H, or groups -OR<1><0> wherein R<1><0> is hydrogen or C1-4 straight or branch chain alkyl, provided that the total number of carbon atoms in the group -AY is from 0 to 20; or R<7> and Y together may form a C2-7 polymethylene chain optionally substituted by one or two C1-4 alkyl groups and optionally interrupted by -O-, -S- or NR<1><1> groups wherein R<1><1> is C1-4 straight or branch chain alkyl; and X<1> is C1 or Br; comprising (a) reacting, optionally in the presence of a solvent and an inorganic or organic acid - binding agent, a compound having the formula II: <CHEM> wherein R<2> and R<3> have their previous significance; R<1> is fluorine, chlorine or bromine; and X is chlorine, bromine or iodine with the proviso that, when X is chlorine, none of R<1>, R<2>, R<3>, R<4>, R<5> and R<6> can be bromine; with a compound of formula H-Z III wherein Z has its previous significance: and (b) when Z is -AY and -AY is -OH, the product of step a) is optionally reacted with a compound IV capable of converting a carboxyl group into the corresponding carboxylic acid chloride or -bromide, thereby producing a compound of formula I wherein Z is- X<1> as well as the use of the compounds of formula I in antifungal and antibacterial compositions.
Patent IL-78059-A0 (IL)
Title: Pyrido(2,3-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/495
Filed: 1986-03-06
Abstract: 2,4-Diamino- and 2-amino-4-hydroxy- derivatives of N-(4-[2-(pyrido[2,3-d]pyrimidin-6-yl)alkyl]-benzoyl)-L-glutamic acids, and the corresponding 5,6,7,8- tetrahydro compounds are antineoplastic agents.The compounds are prepared by hydrolytic or hydrogenolytic removal of carboxylic acid protecting groups from the correspondingly protected glutamic acid derivatives. A typical embodiment is N-(4-[2-(2-amino-4-hydroxy-5,6,7,8,-tetrahydropyrido[2-3-d]pyrimidin-6 -yl)-ethyl]benzoyl)-L-glutamic acid.
Patent IL-85601-A0 (IL)
Title: Device for transporting cooked or refrigerated food
IPC: A21B3/07
Filed: 1988-03-01
Abstract: PCT No. PCT/FR88/00112 Sec. 371 Date Jan. 3, 1989 Sec. 102(e) Date Jan. 3, 1989 PCT Filed Feb. 29, 1988 PCT Pub. No. WO88/06408 PCT Pub. Date Sep. 7, 1988.An apparatus for preparing foods for predeterminable period of time. One embodiment of the apparatus is for cooking; another is for refrigeration. The apparatus includes either a cooking container or a refrigeration container, a conveyor for carrying food products to and from this container, and a robot assembly for removing food products from the conveyor, inserting them into the container, extracting them from the container after the predetermined cooking or refrigeration period, and returning them to the conveyor. The robot assembly is programmable to extract and return these food products after cooking or refrigeration for a predeterminable period of time.
Patent IL-95305-A0 (IL)
Title: Agrochemical compositions
IPC: A01N25/16
Filed: 1990-08-06
Abstract: A fungicidal, herbicidal or plant growth regulating composition for application to an aquatic environment, the composition comprising a solid carrier, a fungicidal, herbicidal or plant growth regulating active ingredient, and an oil with which the said active ingredient is miscible or in which it is capable of being dispersed, said oil being water-immiscible, having a specific gravity of less than 1 and a boiling point at atmospheric pressure of greater than 150 DEG C. The compositions are particularly useful for application to a paddy-field to assist in the cultivation of rice.
Patent IL-95456-A0 (IL)
Title: Collagen compositions and their preparation
IPC: A61L27/00
Filed: 1990-08-22
Abstract: This invention relates to collagen compositions and methods of preparing such compositions. This invention also relates to a novel source of collagen, the common digital extensor tendon.
Patent FI-20015023-A0 (FI)
Inventor: AHVENAINEN PASI
IPC: D21G9/00
Filed: 2001-08-22
Abstract: An apparatus for leading a web threading tail over an empty space formed between two surfaces, between which the apparatus ( 10 ) is arranged. The apparatus ( 10 ) includes a belt loop ( 28 ) permeable by air, which is supported by turnover rolls ( 29, 30 ). Within the belt loop ( 28 ) at least one foil strip ( 31 ) is arranged for creating a vacuum effect in the part of the belt loop ( 28 ) that transports the web threading tail ( 16 ) from the surface preceding the empty space, and to lead it to the following surface, a vacuum effect is arranged in connection with the first turnover roll ( 29 ) of the turnover rolls ( 29, 30 ).
Patent IL-103238-A0 (IL)
Title: Pressurised aerosol compositions
IPC: A61K38/35
Filed: 1992-09-22
Abstract: A pressurised aerosol composition comprising a liquefied hydrofluoroalkane, a powdered medicament dispersable therein and a polymer soluble in the liquefied hydrofluoroalkane, wherein the polymer includes recurring structural units, the units being selected from amide containing units and carboxylic acid ester containing units.
Patent IL-105763-A0 (IL)
Title: Clostridium perfringens vaccines
IPC: C12N15/55
Filed: 1993-05-20
Abstract: The present invention provides novel peptides and vaccines containing them capable or inducing production of antibodies directed against Clostridium perfringens alph-toxin (CPa) in animals to which the) arc administered and thereby providing pro-phylazis against infection by Clostridium pefringens and/or the alpha-toxin itself. Particularly the present invention provides such a vaccine that is relatively safe and simple to produce. e.g. by genetic engineering means. Preferred peptides comprise theo amino acid sequence of Clostridium perfringens alpha-toxin from amino acid 247 to 370 but lack the epitopes necessary for phos-pholipase C and/or sphingomyelin hydrolysing activity round between amino acids 1 to 240 of that sequence. Further provided are antisera and antibodies raised to the peptides and vaccines of the present invention, and particularly monoclonal antibodies and hybridoma cell lines for their production.
Patent IL-138171-A0 (IL)
Title: Process for producing direct tooling mold and method for using the same
IPC: B29C33/38
Filed: 1999-03-05
Abstract: The present invention relates to a method for making a prototype by providing at least one polymeric board material having a glass transition temperature less than the molten temperature of a thermoplastic molding material and removing at least a portion of the polymeric board material to form, according to a computer-aided design, a reverse image of a desired article to be molded. Selected molten polymeric molding material is injected into the resulting mold to produce the desired prototype.
Patent IL-139164-A0 (IL)
Title: Riluzole and levodopa combinations for treating parkinson's disease
IPC: A61K45/06
Filed: 1999-04-22
Abstract: The invention concerns a combination of levodopa and riluzole or a pharmaceutically acceptable salt of said compound and the use of said combination for treating Parkinson Disease.
Patent IL-143429-A0 (IL)
Title: Method and apparatus for configuring a rake receiver
IPC: H04B1/7115
Filed: 1999-11-26
Abstract: A searcher uses an input signal, and for example, a matched filter to generate a first set of candidate paths. A selector uses the input signal and the first set of candidate paths to generate a second set of paths. The second set of paths is used to configure the fingers of a RAKE receiver. According to one aspect of the invention, the first set of candidate paths contains M paths, and the second stage uses M correlators to generate a set of M correlation values. The second stage uses the M correlation values to select N paths that are used to configure the N fingers of the RAKE receiver. According to another aspect of the invention, the first set of candidate paths contains M paths, and the second stage uses a multiple of M correlators to track the M paths and generate a set of M estimates. The second stage uses the M estimates to select N paths that are used to configure the N fingers of the RAKE receiver. According to another aspect of the invention, the selector can generate new sets of N paths while the searcher is either active or inactive. The receiver can use a quality signal or a counter to notify the searcher and/or the selector to generate new sets of paths. The selector decreases the need to continuously run the matched filter. The receiver can re-configure the fingers without having to search for new paths. The receiver can also find paths that are uncorrelated and less susceptible to fading.
Patent IL-144778-A0 (IL)
Title: Protective device against the effects of explosives
IPC: F41H11/12
Filed: 2000-02-21
Abstract: An appliance for protecting the bottom end of a human lower limb, and in particular the foot, from propagation of the blast wave and the heat generated by an explosive device of the mine type exploding. The invention provides an ammunition type boot whose sole is constituted by an assembly comprising a dispersion boat-shape, an antifire barrier, and support studs. The assembly provides simultaneously an optimum dispersion effect and satisfactory use for walking and running on any type of ground. It also withstands the explosion, and the heat, and it does not create puncturing projectiles because it constitutes a homogeneous assembly.
Patent IL-149401-A0 (IL)
Title: 1-amino-alkylcyclohexane nmda receptor antagonists
IPC: A61K31/40
Filed: 1999-11-01
Abstract: Certain 1-cyclic amino-alkylcyclohexanes selected from the group consisting of those of formula (I) wherein R* is -(CH2)n-(CR<6>R<7>)m-NR<8>R<9>; wherein n+m=0,1, or 2; wherein R<1> through R<7> are independently selected from the group consisting of hydrogen and lower-alkyl (1-6c), at least R<1>, R<4>, and R<5> being lower-alkyl, and wherein R<8> and R<9> together represent lower-alkylene -(CH2)x- wherein x is 2 to 5, inclusive, and enantiomers, optical isomers, hydrates, and pharmaceutically acceptable salts thereof, are systemically active uncompetitive NMDA receptor antagonists and are therefore useful in the alleviation of conditions resulting from disturbances of glutamatergic transmission.  More importantly, these compounds exhibit outstanding anticonvulsant and anti-seizure activity which is not shared by closely-related noncyclic amino compounds.  Pharmaceutical compositions thereof and a method-of-treating conditions which are alleviated by the employment of the same, especially the alleviation of convulsions and seizures, and method for the preparation of the active 1-cyclic amino-alkylcyclohexane compounds involved and the manufacture of medicaments therefrom.
Patent IL-152322-A0 (IL)
Title: Artificial retina device with stimulating and ground return electrodes disposed on opposite sides of the neuroretina and method of attachment
IPC: A61F9/08
Filed: 2001-05-01
Abstract: The present invention provides an artificial retina device (10) for electrically stimulating a neuroretina of an eye to produce artificial vision. The artificial retina device (10) comprises: a stimulating electrode unit (12) having at least one stimulating electrode (23b, 27) for connection with an electrical source; and a ground return electrode unit (16) having at least one ground return electrode (14, 14a) for connection with the electrical source. The at least one stimulating electrode (23b, 27) of the stimulating electrode unit (12) is configured to be disposed or implanted for electrical contact with at least one of individual cells, groups of cells, portions of cells and nerve fibers of the neuroretina, and the at least one ground return electrode (14, 14a) of the ground return electrode unit (16) is configured to be disposed or implanted at a position spaced from the stimulating electrode unit (12) for transretinal stimulation of the neuroretina. The at least one stimulating electrode (23b, 27) and the at least one ground return electrode (14, 14a) are desirably configured to be disposed or implanted on opposite sides of the neuroretina.
Patent IL-153549-A0 (IL)
Title: Spectacles with wire-like branches
IPC: G02C5/14
Filed: 2001-07-02
Abstract: Eyeglasses have a vertical midplane of symmetry and comprise a front optical portion and two wire temples each associated with a respective side zone of the front optical portion. Each temple has a hinge end shaped as an eyelet lying in a vertical plane intersecting a general longitudinal direction of the temple. A hinge element is fixed on an inside surface of the corresponding side zone to receive the eyelet to pivot about an axis that is substantially normal to said inside surface, between a deployed position in which the temple is substantially perpendicular to the front optical portion, and a folded position in which the temple is substantially parallel to the front optical portion.
Patent IL-157552-A0 (IL)
Title: Enantioselective synthesis of azetidinone intermediate compounds
IPC: C07D263/26
Filed: 2002-03-25
Abstract: The application relates to a process for preparing a compound of Formula IThis compound is an intermediate used to produce compounds that are useful as hypocholesterolemic agents in the treatment and prevention of atheroschlerosis.